Ionis to Present at Upcoming Investor Conferences

BusinesswireFeb 25 07:05 ET

Stifel Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $38

Moomoo NewsFeb 24 21:32 ET · Ratings

Stifel Nicolaus Remains a Hold on Ionis Pharmaceuticals (IONS)

TipRanksFeb 24 21:09 ET · Ratings

Insider Sale: EVP CLO & General Counsel of $IONS Sells 1,207 Shares

Quiver QuantitativeFeb 24 17:02 ET

Express News | Ionis Pharmaceuticals Inc : Leerink Partners Raises Target Price to $52 From $50

ReutersFeb 24 07:31 ET

Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives

TipRanksFeb 23 06:06 ET